The Envelope Protein of SARS-CoV-2 Inhibits Viral Protein Synthesis and Infectivity of Human Immunodeficiency Virus type 1 (HIV-1)Wyatt Henke(University of Kansas Medical Center), Edward B. Stephens(University of Kansas Medical Center)bioRxiv (Cold Spring Harbor Laboratory)March 27, 202210.1101/2022.03.23.485576Cited by 2SaveCiteExport RISWatch citationsRelated PapersThe envelope proteins from SARS-CoV-2 and SARS-CoV potently reduce the infectivity of human immunodeficiency virus type 1 (HIV-1)|Retrovirology|2022|4A Viroporin from SARS-CoV-2 Reduces the Infectivity of Human Immunodeficiency Virus type 1 (HIV-1)|Research Square|2022|0The Envelope Proteins from SARS-CoV-2 and SARS-CoV Potently Reduce the Infectivity of Human Immunodeficiency Virus type 1 (HIV-1)|Research Square|2022|0